MS patients denied licensed cannabis drug by NHS
MS patients denied licensed cannabis drug by NHS
The NHS has been criticised by doctors for denying multiple sclerosis patients access to a drug derived from cannabis which regulators have approved to help relieve their symptoms.
MS specialists claim primary care trusts (PCTs) in England are exacerbating patients' pain and suffering by refusing to let them use Sativex. Some PCTs say the drug, which costs £11 a day, is not worth the money, but doctors insist it is the only medication that can help some patients.
Sativex can relieve spasticity, or muscle stiffness, in MS patients. It became the first cannabis-based medicine to be licensed for use in the UK almost a year ago by the Medicines and Healthcare products Regulatory Agency (MHRA). ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1814
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1526 Views
-
Last post by frodo
-
- 0 Replies
- 1519 Views
-
Last post by NHE
-
- 0 Replies
- 479 Views
-
Last post by NHE
-
- 0 Replies
- 1608 Views
-
Last post by NHE
-
- 1 Replies
- 3072 Views
-
Last post by Tif
-
- 0 Replies
- 2356 Views
-
Last post by frodo
-
- 5 Replies
- 13890 Views
-
Last post by gibbledygook
-
- 2 Replies
- 987 Views
-
Last post by DIM
-
- 1 Replies
- 1919 Views
-
Last post by raceya